The mission of the Emory Center for AIDS Research (CFAR) is to foster and enhance HIV/AIDS research for the purpose of preventing or mitigating the suffering caused by HIV. The Emory CFAR will accomplish this mission by meeting three objectives: 1. Foster the collaborative interdisciplinary research of HIV investigators by providing administrative support, establishing critical shared core resources, and enhancing communications through seminars and training activities. 2. Stimulate the entry of new investigators into HIV research through targeted research mentoring and training and the continuation of our successful peer-reviewed competitive development seed grant program. These programs will continue to seek to attract minority investigators. 3. Promote high quality HIV research at Emory University Departments and Centers in the recruitment of key faculty and supporting priority HIV research activities. The Emory CFAR will be led by an Advisory Board composed of the CFAR Director, Dr. James Curran, the CFAR Associates Directors and Assistant Director, the Core Directors, and several key HIV/AIDS scientists and science administrators in the Woodruff Health Science Center of Emory University. The Emory CFAR serves over 60 NIH-funded HIV/AIDS Principal Investigators as well as more than 60 other HIV/AIDS investigators who are not currently serving as PI on a HIV/AIDS-related NIH grant. Seven core facilities are proposed to meet the CFAR objectives. These include administrative, developmental, biostatistics, behavioral & social sciences, clinical research, immunology, and virology/pharmacology. Services provided by these cores will be critical in facilitating growth in all aspects of Emory University's four principal HIV/AIDS research areas?prevention science, clinical science, HIV pathogenesis, and vaccine development?as well as in Emory's two main HIV/AIDS interdisciplinary activities: training and international research. Since the inception of the Emory CFAR with institutional support in 1997, the growth in scope and vitality of HIV research as Emory has been extraordinary. The CFAR has fostered recruit of over thirty additional faculty in HIV research into an interdisciplinary environment at Emory. The CFAR has attracted substantially increased institutional support to further facilitate the growth and quality of HIV/AIDS research. Under CFAR leadership, extramural HIV research funding at Emory has grown from $23 million ($11 million NIH) in 1996 to over $44 million ($33.5 million NIH) in 2000.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050409-05
Application #
6663761
Study Section
Special Emphasis Panel (ZAI1-HSD-A (J1))
Program Officer
Young, Janet M
Project Start
2002-09-30
Project End
2007-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
5
Fiscal Year
2003
Total Cost
$1,425,219
Indirect Cost
Name
Emory University
Department
Type
Schools of Public Health
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Holloway, Ian W; Bednarczyk, Robert; Fenimore, Vincent L et al. (2018) Factors Associated with Immunization Opinion Leadership among Men Who Have Sex with Men in Los Angeles, California. Int J Environ Res Public Health 15:
Halpin, Sean N; Carruth, Edwin Clayton; Rai, Ramona P et al. (2018) Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment. AIDS Behav 22:848-852
Ke, Zunlong; Strauss, Joshua D; Hampton, Cheri M et al. (2018) Promotion of virus assembly and organization by the measles virus matrix protein. Nat Commun 9:1736
Kalichman, Seth C; Cherry, Chauncey; Kalichman, Moira O et al. (2018) Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP). J Acquir Immune Defic Syndr 78:34-42
Singleton, Robyn; Winskell, Kate; Nkambule-Vilakati, Siphiwe et al. (2018) Young Africans' social representations of rape in their HIV-related creative narratives, 2005-2014: Rape myths and alternative narratives. Soc Sci Med 198:112-120
Palesch, David; Bosinger, Steven E; Tharp, Gregory K et al. (2018) Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host. Nature 553:77-81
Sullivan, Patrick S (2018) Practical Considerations for Implementing a New Syphilis Action Plan. Sex Transm Dis 45:S78-S79
Sullivan, Patrick S; Giler, Robertino Mera; Mouhanna, Farah et al. (2018) Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. Ann Epidemiol 28:833-840
Dillard, Rebecca S; Hampton, Cheri M; Strauss, Joshua D et al. (2018) Biological Applications at the Cutting Edge of Cryo-Electron Microscopy. Microsc Microanal 24:406-419
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187

Showing the most recent 10 out of 1005 publications